Coronavirus Update: 'We Are Racing Against The Virus, Not America,' Says China’s Vaccine Frontrunner

Plus new biotech company Adagio Therapeutics has been launched with a $50m series A financing to advance its coronavirus antibodies as therapeutics and prophylactics.